Imunon, Inc. Convertible Preferred Stock, Shares Reserved for Future Issuance
Imunon, Inc. (IMNN) had Convertible Preferred Stock, Shares Reserved for Future Issuance of 2.68 million shares as of 2013-02-26, per its 10-Q filed 2013-11-12.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:ConvertiblePreferredStockSharesReservedForFutureIssuance · last filed 2013-11-12
- 2013-02-26: Convertible Preferred Stock, Shares Reserved for Future Issuance 2.68M shares; Convertible Preferred Stock, Shares Reserved for Future Issuance as first filed 12.07M shares.
| Period end | Convertible Preferred Stock, Shares Reserved for Future Issuance | Convertible Preferred Stock, Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2013-02-26 | 2.68M shares 10-Q · filed 2013-11-12 | 12.07M shares 10-Q · filed 2013-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |